Sesbania: A Prospective Candidate to be Excavated for Anticancer Drugs

Publisher： Bentham Science Publishers

E-ISSN： 2210-3163|5|4|273-287

ISSN： 2210-3155

Source： The Natural Products Journal, Vol.5, Iss.4, 2015-12, pp. : 273-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Organometallic Ruthenium(II) Anticancer (RAPTA) Drugs

By Ang Wee Han  

CHIMIA International Journal for Chemistry, Vol. 61, Iss. 4, 2007-04 ,pp. : 140-142

Swiss Chemical Society

Access to resources Recommend Favorite

Nature as Source and Inspiration for the Synthesis of New Anticancer Drugs

By  

Frontiers in Natural Product Chemistry, Vol. 1, Iss. 1, 2005-01 ,pp. : 51-54

Bentham Science Publishers

Access to resources Recommend Favorite

In vitro metabolism of the lignan (−)‐grandisin, an anticancer drug candidate, by human liver microsomes

By  

DRUG TESTING AND ANALYSIS, Vol. 7, Iss. 9, 2015-09 ,pp. : 780-786

John Wiley & Sons Inc

Access to resources Recommend Favorite

Binding of ansa- and non-ansa-titanocene anticancer drugs to DNA: a DFT study

By Deng Chunqiang   Zhou Lixin  

Structural Chemistry, Vol. 21, Iss. 4, 2010-08 ,pp. : 735-744

Springer Publishing Company

Access to resources Recommend Favorite

Ornithine Aminotransferase versus GABA Aminotransferase: Implications for the Design of New Anticancer Drugs

By  

MEDICINAL RESEARCH REVIEWS, Vol. 35, Iss. 2, 2015-03 ,pp. : 286-305

John Wiley & Sons Inc

Access to resources Recommend Favorite